BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27035535)

  • 1. Critical Appraisal of Existing Ketamine Trials: Existing Limitations and Limited Applicability for Treatment.
    Zhang MW; Ho R
    Am J Psychiatry; 2016 Apr; 173(4):431. PubMed ID: 27035535
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Zhang and Ho: Addressing Ketamine's Use in Depression.
    Newport DJ; Nemeroff CB
    Am J Psychiatry; 2016 Apr; 173(4):431-2. PubMed ID: 27035536
    [No Abstract]   [Full Text] [Related]  

  • 3. Exploiting N-methyl-d-aspartate channel blockade for a rapid antidepressant response in major depressive disorder.
    Blier P
    Biol Psychiatry; 2013 Aug; 74(4):238-9. PubMed ID: 23885752
    [No Abstract]   [Full Text] [Related]  

  • 4. Ketamine as an alternative treatment for treatment-resistant depression.
    Dowben JS; Grant JS; Keltner NL
    Perspect Psychiatr Care; 2013 Jan; 49(1):2-4. PubMed ID: 23293991
    [No Abstract]   [Full Text] [Related]  

  • 5. Ketamine for Treatment-Resistant Depression: a New Advocate.
    Pérez-Esparza R
    Rev Invest Clin; 2018; 70(2):65-7. PubMed ID: 29718013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.
    Newport DJ; Carpenter LL; McDonald WM; Potash JB; Tohen M; Nemeroff CB;
    Am J Psychiatry; 2015 Oct; 172(10):950-66. PubMed ID: 26423481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-methyl-D-aspartate glutamate receptor antagonists and the promise of rapid-acting antidepressants.
    Krystal JH
    Arch Gen Psychiatry; 2010 Nov; 67(11):1110-1. PubMed ID: 21041611
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
    Zarate CA; Singh JB; Carlson PJ; Brutsche NE; Ameli R; Luckenbaugh DA; Charney DS; Manji HK
    Arch Gen Psychiatry; 2006 Aug; 63(8):856-64. PubMed ID: 16894061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A word to the wise about ketamine.
    Schatzberg AF
    Am J Psychiatry; 2014 Mar; 171(3):262-4. PubMed ID: 24585328
    [No Abstract]   [Full Text] [Related]  

  • 10. Electroconvulsive therapy is a standard treatment; ketamine is not (yet).
    Kellner CH; Greenberg RM; Ahle GM; Liebman LS
    Am J Psychiatry; 2014 Jul; 171(7):796. PubMed ID: 24980176
    [No Abstract]   [Full Text] [Related]  

  • 11. Ketamine followed by memantine for the treatment of major depression.
    Kollmar R; Markovic K; Thürauf N; Schmitt H; Kornhuber J
    Aust N Z J Psychiatry; 2008 Feb; 42(2):170. PubMed ID: 18197514
    [No Abstract]   [Full Text] [Related]  

  • 12. Ketamine for treatment-resistant depression: ready or not for clinical use?
    Rush AJ
    Am J Psychiatry; 2013 Oct; 170(10):1079-81. PubMed ID: 23982324
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.
    Ghasemi M; Kazemi MH; Yoosefi A; Ghasemi A; Paragomi P; Amini H; Afzali MH
    Psychiatry Res; 2014 Feb; 215(2):355-61. PubMed ID: 24374115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid antidepressant effects of ketamine ignite drug discovery.
    Dolgin E
    Nat Med; 2013 Jan; 19(1):8. PubMed ID: 23295995
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-lasting effects of a single subcutaneous dose of ketamine for treating melancholic depression: a case report.
    Gálvez V; O'Keefe E; Cotiga L; Leyden J; Harper S; Glue P; Mitchell PB; Somogyi AA; DeLory A; Loo CK
    Biol Psychiatry; 2014 Aug; 76(3):e1-2. PubMed ID: 24507509
    [No Abstract]   [Full Text] [Related]  

  • 16. Ketamine and the potential role for rapid-acting antidepressant medications.
    Krystal JH
    Swiss Med Wkly; 2007 Apr; 137(15-16):215-6. PubMed ID: 17525875
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ketamine for treatment of acute depression].
    Hjerrild S; Bjerre J; Pedersen RH; Videbech P
    Ugeskr Laeger; 2013 Sep; 175(37):2090-3. PubMed ID: 24011203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking NMDA receptor at rest: a possible alleviation of depression.
    Lu W
    Acta Pharmacol Sin; 2011 Sep; 32(9):1087-8. PubMed ID: 21804573
    [No Abstract]   [Full Text] [Related]  

  • 19. NMDA antagonist treatment of depression.
    Williams NR; Schatzberg AF
    Curr Opin Neurobiol; 2016 Feb; 36():112-7. PubMed ID: 26687375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained antidepressant response to ketamine.
    Atigari OV; Healy D
    BMJ Case Rep; 2013 Aug; 2013():. PubMed ID: 23960151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.